Ergoteles’s Apollo Endosurgery, Inc. APEN Stock Holding History

Ergoteles’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,414,792	Closed	-$14M	–	1724
2023 Q1	$14M	Buy	+1,414,792	New	+$14M	0.55%	31
2022 Q3	–	Sell	-21,424	Closed	-$78K	–	2168
2022 Q2	$78K	Buy	+21,424	New	+$101K	﹤0.01%	1538

Ergoteles's APEN Position: Q2 2023 in Review

Ergoteles sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,414,792 shares — an estimated $14M sold.

Ergoteles first reported a position in APEN in Q2 2022 and held it in 2 quarters. The position peaked at $14M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Ergoteles reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 1,414,792 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $14M.
Ergoteles first reported a position in Apollo Endosurgery, Inc. in Q2 2022 and held it in 2 quarters.
Ergoteles's Apollo Endosurgery, Inc. position peaked at $14M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.